Tobacco Free Policies and Interventions in Behavioral Health Care Settings
Professor of Psychiatry, University of Colorado, School of Medicine
Chad D Morris, Ph.D. is a Professor of Psychiatry at the University of Colorado- School of Medicine, and Director of the Behavioral Health & Wellness Program. He is the principal investigator of many projects and studies exploring the effectiveness of organizational, psychosocial, and pharmacologic wellness and tobacco cessation strategies. As the Vice President of Spark Inspiration, Dr. Morris also offers corporate wellness solutions. He has worked with over 40 states to foster sustainable whole health and tobacco control initiatives for priority populations including persons with mental illnesses, addictions, and justice involved individuals.
Integrated Care Systems Program Manager at Integral Care
Tim is the Integrated Care Systems Program Manager at Integral Care, the Local Mental Health Authority in Austin, TX. Tim integrates wellness services, such as tobacco cessation and nutrition, into clinical settings across the agency. He has 5 years of experience in tobacco cessation interventions in behavioral health settings and from 2014-2017 Tim worked for the Taking Texas Tobacco Free project, helping 22 mental health centers across Texas adopt Tobacco Free policies and implement tobacco cessation interventions.
Identify proven steps toward bringing your agency tobacco free
Discuss how to effectively enforce a tobacco free grounds policy
Describe how to implement tobacco cessation interventions into clinical practice.
Identify and overcome common barriers experienced during tobacco free policy implementation
The CME/CEU registration site has closed. Credit will be available again for the recorded version of the webinar by January.
Certificates of Attendance
Click here to generate a certificate of attendance (best viewed in Adobe Acrobat).
This UCSF CME activity was planned and developed to uphold academic standards to ensure balance, independence, objectivity, and scientific rigor; adhere to requirements to protect health information under the Health Insurance Portability and Accountability Act of 1996 (HIPAA); and include a mechanism to inform learners when unapproved or unlabeled uses of therapeutic products or agents are discussed or referenced.
The following speakers, moderators and planning committee members have disclosed they have no financial interest/arrangement or affiliation with any commercial companies who have provided products or services relating to their presentation(s) or commercial support for this continuing medical education activity:
Christine Cheng, Brian Clark, Jennifer Lucero, MA, MS, Jennifer Matekuare, Chad D. Morris, PhD, Jessica Safier, MA, Catherine Saucedo, Steven A. Schroeder, MD, and Timothy Stacey, LPC-S